TP53 and neoplasm: Extensive research demonstrated that 89 effectively killed TNBC cells with three gain-of-function mutations (R280K, R248Q, and R175H) or deleted p53 in two-dimensional and three-dimensional culture models, patient explants, and tumour xenografts by activating the p53 family member TAp73.